Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Disputing the facts: Is the legal battle between Veeva and IQVIA an antitrust issue?

Antitrust legislation aims to prevent companies from acting in a way that is detrimental to both the industry and the patients it serves. Veeva alleges its competitor IQVIA has breached antitrust regulations by not allowing its data to be used in newer Veeva platforms, while IQVIA responds that Veeva has stolen and misused its data to improve its own offerings. Allie Nawrat speaks to both sides about the legal dispute.


Go Top